BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 25266748)

  • 1. A rare but severe pulmonary side effect of cetuximab in two patients.
    Achermann Y; Frauenfelder T; Obrist S; Zaugg K; Corti N; Günthard HF
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22843749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab-induced diffuse myositis in a patient of metastatic colon cancer: a case report.
    Islam MM
    Clin Med (Lond); 2023 Nov; 23(Suppl 6):15. PubMed ID: 38182229
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-resectable metastases from colorectal cancers].
    Di Fiore F
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S140-4. PubMed ID: 18468824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management for adverse events associated with FOLFIRI plus cetuximab or panitumumab].
    Masuishi T; Muro K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():587-91. PubMed ID: 25831828
    [No Abstract]   [Full Text] [Related]  

  • 5. NCCN guideline updates: colon and rectal cancers, version 1.2004.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
    [No Abstract]   [Full Text] [Related]  

  • 6. Current stages of adjuvant treatment of colon cancer.
    Köhne CH
    Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor.
    Mizuno T; Tanegashima T; Suzuki A; Kuze S; Koyama T
    Eur J Dermatol; 2014; 24(4):511-2. PubMed ID: 25266748
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
    Grothey E; Chu E
    Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?
    Fakih M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1471-80. PubMed ID: 18759698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab in metastatic colorectal cancer.
    Broadbridge VT; Karapetis CS; Price TJ
    Expert Rev Anticancer Ther; 2012 May; 12(5):555-65. PubMed ID: 22594891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
    Cheng AL; Li J; Vaid AK; Ma BB; Teh C; Ahn JB; Bello M; Charoentum C; Chen LT; de Lima Lopes G; Ho GF; Kong HL; Lam KO; Liu TS; Park YS; Sriuranpong V; Sudoyo AW; Wang JY; Zhang J; Zhang SZ; Ciardiello F; Köhne CH; Shaw M; Kim TW
    Clin Colorectal Cancer; 2014 Sep; 13(3):145-55. PubMed ID: 25209093
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.